]>Synthesis and Biological Evaluation of 7-O-Modified Formononetin Derivatives : Table 2
Table 2: Antimicrobial activity of the synthesized compounds.

CompoundsMinimum inhibitory concentrations 0 𝑥 0 𝑓 𝑓 0 8 MICs 0 𝑥 0 𝑓 𝑓 0 9 (μg/mL)
Gram positiveGram negative
S. faecalisS. aureusB. subtilisE. coliP. aeruginosaE. cloacae

13.1225.0050.0050.0025.0050.00
2a3.126.253.126.251.5650.00
2b3.1250.0025.006.2525.001.56
2c3.123.1250.0012.5025.0012.50
3a3.126.2550.003.123.1225.00
3b1.5612.500.783.1250.003.12
3c3.126.256.2525.006.253.12
3d3.126.256.2512.503.126.25
3e3.121.5650.0025.0025.006.25
3f3.1212.5025.006.2550.0025.00
4a3.123.1250.006.2550.0050.00
4b3.1225.003.121.566.2512.50
4c3.1212.5025.006.256.2512.50
4d3.126.253.1212.503.1225.00
4e3.123.1250.001.5650.0050.00
5a3.121.566.2525.006.253.12
5b3.1212.501.5625.0050.0050.00
5c3.1250.001.566.256.2550.00
5d3.1250.0025.006.253.126.25
5e3.120.7812.506.2525.0025.00
5f3.1225.0050.0050.003.121.56

Penicillin1.561.561.566.256.253.12
Kanamycin3.121.560.393.123.121.56